Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 5.04654312 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.84415467 |
3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.72824397 |
4 | synaptic vesicle maturation (GO:0016188) | 4.60614504 |
5 | neuron cell-cell adhesion (GO:0007158) | 4.52819851 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.45890010 |
7 | neuronal action potential propagation (GO:0019227) | 4.43847988 |
8 | glutamate secretion (GO:0014047) | 4.30546839 |
9 | vocalization behavior (GO:0071625) | 4.30444514 |
10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.23489322 |
11 | regulation of synaptic vesicle transport (GO:1902803) | 4.20119482 |
12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.09431587 |
13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.03408818 |
14 | protein localization to synapse (GO:0035418) | 3.99799299 |
15 | presynaptic membrane assembly (GO:0097105) | 3.99769565 |
16 | locomotory exploration behavior (GO:0035641) | 3.87743269 |
17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.82426804 |
18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.76628095 |
19 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.75663332 |
20 | inositol phosphate dephosphorylation (GO:0046855) | 3.75663332 |
21 | neurotransmitter secretion (GO:0007269) | 3.75463878 |
22 | inositol phosphate catabolic process (GO:0071545) | 3.71971189 |
23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.68398083 |
24 | dendritic spine morphogenesis (GO:0060997) | 3.67950536 |
25 | presynaptic membrane organization (GO:0097090) | 3.63518783 |
26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.60608145 |
27 | postsynaptic membrane organization (GO:0001941) | 3.47316442 |
28 | synaptic transmission, glutamatergic (GO:0035249) | 3.46322270 |
29 | glutamate receptor signaling pathway (GO:0007215) | 3.43213082 |
30 | transferrin transport (GO:0033572) | 3.40827824 |
31 | neuron-neuron synaptic transmission (GO:0007270) | 3.39008591 |
32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.38281028 |
33 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.33547490 |
34 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.33547490 |
35 | activated T cell proliferation (GO:0050798) | 3.33541138 |
36 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.32794051 |
37 | nerve growth factor signaling pathway (GO:0038180) | 3.27371115 |
38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26962144 |
39 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25182036 |
40 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25182036 |
41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21283139 |
42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.20728076 |
43 | detection of calcium ion (GO:0005513) | 3.19205363 |
44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.18031814 |
45 | neurotransmitter transport (GO:0006836) | 3.16453604 |
46 | trivalent inorganic cation transport (GO:0072512) | 3.16221546 |
47 | ferric iron transport (GO:0015682) | 3.16221546 |
48 | long-term synaptic potentiation (GO:0060291) | 3.14577003 |
49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.14314541 |
50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.14153063 |
51 | regulation of neurotransmitter secretion (GO:0046928) | 3.14036113 |
52 | positive regulation of membrane potential (GO:0045838) | 3.14030398 |
53 | startle response (GO:0001964) | 3.12962303 |
54 | proline transport (GO:0015824) | 3.12314699 |
55 | synaptic vesicle endocytosis (GO:0048488) | 3.08617056 |
56 | exploration behavior (GO:0035640) | 3.07102980 |
57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.06940865 |
58 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.06192407 |
59 | positive regulation of mitochondrial fission (GO:0090141) | 3.02671326 |
60 | regulation of vesicle fusion (GO:0031338) | 3.02112145 |
61 | glycosphingolipid biosynthetic process (GO:0006688) | 3.01794431 |
62 | vesicle transport along microtubule (GO:0047496) | 3.01410052 |
63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00782745 |
64 | gamma-aminobutyric acid transport (GO:0015812) | 2.99981899 |
65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.99112444 |
66 | phagosome maturation (GO:0090382) | 2.98299368 |
67 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97721139 |
68 | calcium ion-dependent exocytosis (GO:0017156) | 2.97424214 |
69 | cellular potassium ion homeostasis (GO:0030007) | 2.97043932 |
70 | neuromuscular process controlling posture (GO:0050884) | 2.96505807 |
71 | regulation of synapse structural plasticity (GO:0051823) | 2.95642678 |
72 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.93943315 |
73 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.93811549 |
74 | membrane depolarization during action potential (GO:0086010) | 2.92654984 |
75 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90785168 |
76 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.89518910 |
77 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88920326 |
78 | regulation of neurotransmitter transport (GO:0051588) | 2.87679779 |
79 | negative regulation of cell killing (GO:0031342) | 2.86905595 |
80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86905595 |
81 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.83144595 |
82 | regulation of neurotransmitter levels (GO:0001505) | 2.82849188 |
83 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82463219 |
84 | neuron recognition (GO:0008038) | 2.81803711 |
85 | regulation of synaptic plasticity (GO:0048167) | 2.81776767 |
86 | regulation of memory T cell differentiation (GO:0043380) | 2.81688568 |
87 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.80837571 |
88 | positive regulation of granulocyte differentiation (GO:0030854) | 2.80145374 |
89 | activation of protein kinase A activity (GO:0034199) | 2.79650187 |
90 | establishment of synaptic vesicle localization (GO:0097480) | 2.79108354 |
91 | synaptic vesicle transport (GO:0048489) | 2.79108354 |
92 | membrane depolarization (GO:0051899) | 2.78199480 |
93 | transmission of nerve impulse (GO:0019226) | 2.76451157 |
94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76408861 |
95 | long-term memory (GO:0007616) | 2.74012698 |
96 | neural tube formation (GO:0001841) | 2.72984130 |
97 | positive regulation of synapse assembly (GO:0051965) | 2.71958850 |
98 | response to histamine (GO:0034776) | 2.70250615 |
99 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.69851858 |
100 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69544409 |
101 | positive regulation of synaptic transmission (GO:0050806) | 2.68636438 |
102 | protein localization to cilium (GO:0061512) | 2.68280264 |
103 | innervation (GO:0060384) | 2.67782357 |
104 | synapse assembly (GO:0007416) | 2.66428350 |
105 | establishment of vesicle localization (GO:0051650) | 2.66253055 |
106 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.66034849 |
107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.65768952 |
108 | synaptic transmission (GO:0007268) | 2.65609601 |
109 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.65459581 |
110 | regulation of exocytosis (GO:0017157) | 2.65254820 |
111 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.64526828 |
112 | negative regulation of type 2 immune response (GO:0002829) | 2.62314053 |
113 | positive regulation of exocytosis (GO:0045921) | 2.61306718 |
114 | regulation of synaptic transmission (GO:0050804) | 2.60423266 |
115 | regulation of glutamate secretion (GO:0014048) | 2.60221654 |
116 | regulation of regulatory T cell differentiation (GO:0045589) | 2.58887827 |
117 | learning (GO:0007612) | 2.58590475 |
118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58109489 |
119 | polyol catabolic process (GO:0046174) | 2.58065845 |
120 | regulation of respiratory system process (GO:0044065) | 2.56007378 |
121 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.55356027 |
122 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.55235616 |
123 | succinate metabolic process (GO:0006105) | 2.55205296 |
124 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.53183074 |
125 | membrane hyperpolarization (GO:0060081) | 2.52125648 |
126 | regulation of beta-amyloid formation (GO:1902003) | 2.51465003 |
127 | insulin secretion (GO:0030073) | 2.51303391 |
128 | protein targeting to Golgi (GO:0000042) | 2.51255055 |
129 | actin nucleation (GO:0045010) | 2.51158940 |
130 | response to auditory stimulus (GO:0010996) | 2.50273590 |
131 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.49564181 |
132 | positive regulation of meiosis (GO:0045836) | 2.47680283 |
133 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.42601396 |
134 | negative regulation of interleukin-17 production (GO:0032700) | 2.40788069 |
135 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.40640524 |
136 | negative regulation of dendrite development (GO:2000171) | 2.40329641 |
137 | establishment of protein localization to Golgi (GO:0072600) | 2.40313338 |
138 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35928726 |
139 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.31534455 |
140 | negative regulation of membrane potential (GO:0045837) | 2.29682796 |
141 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.28607894 |
142 | auditory behavior (GO:0031223) | 2.28082306 |
143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26504775 |
144 | relaxation of smooth muscle (GO:0044557) | 2.26087454 |
145 | clathrin coat assembly (GO:0048268) | 2.26004311 |
146 | astrocyte differentiation (GO:0048708) | 2.19528021 |
147 | positive regulation of meiotic cell cycle (GO:0051446) | 2.18741686 |
148 | glycolipid biosynthetic process (GO:0009247) | 2.15287204 |
149 | parental behavior (GO:0060746) | 2.14972005 |
150 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.14687477 |
151 | positive regulation of neurotransmitter transport (GO:0051590) | 2.14615058 |
152 | growth hormone receptor signaling pathway (GO:0060396) | 2.14518898 |
153 | positive regulation of mast cell activation (GO:0033005) | 2.14471534 |
154 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.12736270 |
155 | regulation of Rac protein signal transduction (GO:0035020) | 2.12599743 |
156 | regulation of mitochondrial fission (GO:0090140) | 2.10338874 |
157 | positive regulation of Rap GTPase activity (GO:0032854) | 2.10188284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.02936895 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.88599272 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82882888 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81814810 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.67725249 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57959378 |
7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41853340 |
8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.38850236 |
9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38435434 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29386600 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28750087 |
12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24473674 |
13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.21239280 |
14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21154533 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.20960137 |
16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18643789 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17529607 |
18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16818976 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16818976 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01401236 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.00329187 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98497309 |
23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97967986 |
24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95406711 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91688527 |
26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89430149 |
27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86954408 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85802721 |
29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85149268 |
30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85097525 |
31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83612671 |
32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.82046757 |
33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81697175 |
34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79708912 |
35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.79563315 |
36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77487934 |
37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74269470 |
38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72384056 |
39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67359401 |
40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66730084 |
41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63955552 |
42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62439168 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61090809 |
44 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58756045 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57476387 |
46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53879468 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53550002 |
48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50958313 |
49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49292387 |
50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48436791 |
51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48274023 |
52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47703080 |
53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46995100 |
54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45263998 |
55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43077351 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42375234 |
57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41807971 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41034175 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40062774 |
60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39252094 |
61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38869727 |
62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36929149 |
63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36929149 |
64 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36336717 |
65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35360005 |
66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34637109 |
67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34411753 |
68 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.33559888 |
69 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30509995 |
70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29295552 |
71 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29035424 |
72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28814181 |
73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28498876 |
74 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27204500 |
75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26020402 |
76 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25748427 |
77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25538812 |
78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24784788 |
79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23489857 |
80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23114078 |
81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23029987 |
82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22844189 |
83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.22176894 |
84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22092702 |
85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20708368 |
86 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19642999 |
87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19470908 |
88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19142169 |
89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17708476 |
90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17529856 |
91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17283924 |
92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15491140 |
93 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13632123 |
94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13254665 |
95 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12790781 |
96 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.12363519 |
97 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12127472 |
98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12116082 |
99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11862026 |
100 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.11294880 |
101 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.10468748 |
102 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09828823 |
103 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09827893 |
104 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09645826 |
105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09585230 |
106 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08642900 |
107 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.08627594 |
108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08147863 |
109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07440271 |
110 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06488820 |
111 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05613694 |
112 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05566370 |
113 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05505397 |
114 | JUN_21703547_ChIP-Seq_K562_Human | 1.05347861 |
115 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04261938 |
116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03625326 |
117 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03226673 |
118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02882564 |
119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02240686 |
120 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02162745 |
121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01544060 |
122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00746810 |
123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00307701 |
124 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00095925 |
125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00008828 |
126 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.99793399 |
127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98014640 |
128 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97206239 |
129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97206239 |
130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95477585 |
131 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95242532 |
132 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94983545 |
133 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94843513 |
134 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94351105 |
135 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94261378 |
136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93845607 |
137 | AR_19668381_ChIP-Seq_PC3_Human | 0.93472465 |
138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92050555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.82903494 |
2 | MP0003880_abnormal_central_pattern | 4.45075395 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.53956924 |
4 | MP0001968_abnormal_touch/_nociception | 3.31202125 |
5 | MP0004270_analgesia | 3.26250710 |
6 | MP0009745_abnormal_behavioral_response | 3.11046106 |
7 | MP0002735_abnormal_chemical_nociception | 3.04832895 |
8 | MP0002064_seizures | 3.03547301 |
9 | MP0009046_muscle_twitch | 2.92501547 |
10 | MP0002063_abnormal_learning/memory/cond | 2.82076618 |
11 | MP0002736_abnormal_nociception_after | 2.70763348 |
12 | MP0003724_increased_susceptibility_to | 2.67861214 |
13 | MP0002572_abnormal_emotion/affect_behav | 2.63794864 |
14 | MP0002734_abnormal_mechanical_nocicepti | 2.57599924 |
15 | MP0002272_abnormal_nervous_system | 2.45063331 |
16 | MP0006276_abnormal_autonomic_nervous | 2.21834663 |
17 | MP0001970_abnormal_pain_threshold | 2.19951031 |
18 | MP0002733_abnormal_thermal_nociception | 2.19751587 |
19 | MP0005645_abnormal_hypothalamus_physiol | 2.14111337 |
20 | MP0005423_abnormal_somatic_nervous | 2.13913651 |
21 | MP0005646_abnormal_pituitary_gland | 2.10223963 |
22 | MP0002822_catalepsy | 2.08267518 |
23 | MP0001486_abnormal_startle_reflex | 2.06424045 |
24 | MP0001501_abnormal_sleep_pattern | 2.05664379 |
25 | MP0005464_abnormal_platelet_physiology | 2.01330147 |
26 | MP0009780_abnormal_chondrocyte_physiolo | 2.00827547 |
27 | MP0002067_abnormal_sensory_capabilities | 1.99355681 |
28 | MP0002638_abnormal_pupillary_reflex | 1.96850537 |
29 | MP0010386_abnormal_urinary_bladder | 1.96780424 |
30 | MP0001440_abnormal_grooming_behavior | 1.89769228 |
31 | MP0002909_abnormal_adrenal_gland | 1.84813705 |
32 | MP0001986_abnormal_taste_sensitivity | 1.80838745 |
33 | MP0008877_abnormal_DNA_methylation | 1.77969410 |
34 | MP0001984_abnormal_olfaction | 1.77485017 |
35 | MP0006082_CNS_inflammation | 1.73278149 |
36 | MP0003787_abnormal_imprinting | 1.70953580 |
37 | MP0003122_maternal_imprinting | 1.67527410 |
38 | MP0001502_abnormal_circadian_rhythm | 1.63172425 |
39 | MP0001905_abnormal_dopamine_level | 1.61567321 |
40 | MP0008569_lethality_at_weaning | 1.60053935 |
41 | MP0003183_abnormal_peptide_metabolism | 1.59517648 |
42 | MP0002184_abnormal_innervation | 1.59367176 |
43 | MP0004924_abnormal_behavior | 1.55532384 |
44 | MP0005386_behavior/neurological_phenoty | 1.55532384 |
45 | MP0002557_abnormal_social/conspecific_i | 1.50467372 |
46 | MP0001529_abnormal_vocalization | 1.48389706 |
47 | MP0004142_abnormal_muscle_tone | 1.46362009 |
48 | MP0005171_absent_coat_pigmentation | 1.45455750 |
49 | MP0004811_abnormal_neuron_physiology | 1.45225821 |
50 | MP0004858_abnormal_nervous_system | 1.44270308 |
51 | MP0000778_abnormal_nervous_system | 1.41700068 |
52 | MP0001835_abnormal_antigen_presentation | 1.38694546 |
53 | MP0003656_abnormal_erythrocyte_physiolo | 1.36747452 |
54 | MP0003633_abnormal_nervous_system | 1.35695953 |
55 | MP0005174_abnormal_tail_pigmentation | 1.35120606 |
56 | MP0000955_abnormal_spinal_cord | 1.31274831 |
57 | MP0003879_abnormal_hair_cell | 1.29593954 |
58 | MP0001188_hyperpigmentation | 1.27334052 |
59 | MP0005075_abnormal_melanosome_morpholog | 1.26951707 |
60 | MP0002066_abnormal_motor_capabilities/c | 1.25401526 |
61 | MP0005167_abnormal_blood-brain_barrier | 1.25335397 |
62 | MP0000013_abnormal_adipose_tissue | 1.24383891 |
63 | MP0002882_abnormal_neuron_morphology | 1.22984401 |
64 | MP0003195_calcinosis | 1.21741248 |
65 | MP0003121_genomic_imprinting | 1.19536971 |
66 | MP0003329_amyloid_beta_deposits | 1.15548742 |
67 | MP0003303_peritoneal_inflammation | 1.13929888 |
68 | MP0001542_abnormal_bone_strength | 1.13165523 |
69 | MP0002876_abnormal_thyroid_physiology | 1.12842401 |
70 | MP0005387_immune_system_phenotype | 1.12250962 |
71 | MP0001790_abnormal_immune_system | 1.12250962 |
72 | MP0009785_altered_susceptibility_to | 1.12111445 |
73 | MP0004134_abnormal_chest_morphology | 1.09189885 |
74 | MP0000920_abnormal_myelination | 1.07593981 |
75 | MP0005379_endocrine/exocrine_gland_phen | 1.06127690 |
76 | MP0002928_abnormal_bile_duct | 1.05744794 |
77 | MP0005551_abnormal_eye_electrophysiolog | 1.05674068 |
78 | MP0005671_abnormal_response_to | 1.05041817 |
79 | MP0002229_neurodegeneration | 1.03457108 |
80 | MP0001299_abnormal_eye_distance/ | 1.03226761 |
81 | MP0003631_nervous_system_phenotype | 1.03184982 |
82 | MP0003634_abnormal_glial_cell | 1.02493494 |
83 | MP0000372_irregular_coat_pigmentation | 1.02404377 |
84 | MP0004215_abnormal_myocardial_fiber | 1.00368237 |
85 | MP0000465_gastrointestinal_hemorrhage | 1.00356189 |
86 | MP0002148_abnormal_hypersensitivity_rea | 0.99163787 |
87 | MP0002095_abnormal_skin_pigmentation | 0.98183763 |
88 | MP0004484_altered_response_of | 0.97178428 |
89 | MP0004885_abnormal_endolymph | 0.93827692 |
90 | MP0004043_abnormal_pH_regulation | 0.89968083 |
91 | MP0001800_abnormal_humoral_immune | 0.89555191 |
92 | MP0005535_abnormal_body_temperature | 0.89331193 |
93 | MP0002723_abnormal_immune_serum | 0.88752465 |
94 | MP0002693_abnormal_pancreas_physiology | 0.88445612 |
95 | MP0000230_abnormal_systemic_arterial | 0.88248727 |
96 | MP0000343_altered_response_to | 0.88235959 |
97 | MP0006072_abnormal_retinal_apoptosis | 0.87284910 |
98 | MP0005000_abnormal_immune_tolerance | 0.86973783 |
99 | MP0005084_abnormal_gallbladder_morpholo | 0.86329940 |
100 | MP0003690_abnormal_glial_cell | 0.86244570 |
101 | MP0004742_abnormal_vestibular_system | 0.86127999 |
102 | MP0000631_abnormal_neuroendocrine_gland | 0.84122223 |
103 | MP0002163_abnormal_gland_morphology | 0.83835538 |
104 | MP0003172_abnormal_lysosome_physiology | 0.83201392 |
105 | MP0001756_abnormal_urination | 0.81160277 |
106 | MP0005310_abnormal_salivary_gland | 0.80151657 |
107 | MP0001963_abnormal_hearing_physiology | 0.79905275 |
108 | MP0008874_decreased_physiological_sensi | 0.79685753 |
109 | MP0000569_abnormal_digit_pigmentation | 0.79423746 |
110 | MP0002069_abnormal_eating/drinking_beha | 0.79192042 |
111 | MP0005253_abnormal_eye_physiology | 0.79071726 |
112 | MP0002837_dystrophic_cardiac_calcinosis | 0.78209142 |
113 | MP0006036_abnormal_mitochondrial_physio | 0.75249128 |
114 | MP0002419_abnormal_innate_immunity | 0.75039500 |
115 | MP0004145_abnormal_muscle_electrophysio | 0.75008458 |
116 | MP0003828_pulmonary_edema | 0.74177311 |
117 | MP0003763_abnormal_thymus_physiology | 0.74077558 |
118 | MP0004510_myositis | 0.73903200 |
119 | MP0002090_abnormal_vision | 0.73817871 |
120 | MP0000604_amyloidosis | 0.72899087 |
121 | MP0002152_abnormal_brain_morphology | 0.72831778 |
122 | MP0008260_abnormal_autophagy | 0.72691724 |
123 | MP0002752_abnormal_somatic_nervous | 0.66890388 |
124 | MP0000015_abnormal_ear_pigmentation | 0.62625062 |
125 | MP0002751_abnormal_autonomic_nervous | 0.59806826 |
126 | MP0005410_abnormal_fertilization | 0.58881706 |
127 | MP0005394_taste/olfaction_phenotype | 0.57414337 |
128 | MP0005499_abnormal_olfactory_system | 0.57414337 |
129 | MP0001664_abnormal_digestion | 0.57369920 |
130 | MP0001765_abnormal_ion_homeostasis | 0.57224386 |
131 | MP0003075_altered_response_to | 0.56819201 |
132 | MP0004085_abnormal_heartbeat | 0.55974820 |
133 | MP0003136_yellow_coat_color | 0.55174080 |
134 | MP0003632_abnormal_nervous_system | 0.55155311 |
135 | MP0000681_abnormal_thyroid_gland | 0.52202480 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.98247525 |
2 | Myokymia (HP:0002411) | 5.41948034 |
3 | Atonic seizures (HP:0010819) | 5.12921792 |
4 | Epileptic encephalopathy (HP:0200134) | 4.67972772 |
5 | Febrile seizures (HP:0002373) | 4.56353707 |
6 | Focal seizures (HP:0007359) | 4.50300219 |
7 | Visual hallucinations (HP:0002367) | 4.16725882 |
8 | Metaphyseal dysplasia (HP:0100255) | 3.92420071 |
9 | Absence seizures (HP:0002121) | 3.92089166 |
10 | Pheochromocytoma (HP:0002666) | 3.84787673 |
11 | Hyperventilation (HP:0002883) | 3.78629953 |
12 | Progressive cerebellar ataxia (HP:0002073) | 3.75063869 |
13 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.64974160 |
14 | Dialeptic seizures (HP:0011146) | 3.64921298 |
15 | Neuroendocrine neoplasm (HP:0100634) | 3.62727025 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 3.34807925 |
17 | Action tremor (HP:0002345) | 3.09940584 |
18 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.05414328 |
19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.05414328 |
20 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.01009144 |
21 | Intention tremor (HP:0002080) | 3.00629362 |
22 | Hypothermia (HP:0002045) | 3.00105713 |
23 | Episodic fever (HP:0001954) | 2.99535570 |
24 | Supranuclear gaze palsy (HP:0000605) | 2.97409621 |
25 | Progressive inability to walk (HP:0002505) | 2.93764859 |
26 | Broad-based gait (HP:0002136) | 2.92232444 |
27 | Prolonged bleeding time (HP:0003010) | 2.85030083 |
28 | Medial flaring of the eyebrow (HP:0010747) | 2.77117837 |
29 | Anxiety (HP:0000739) | 2.77080303 |
30 | Gait imbalance (HP:0002141) | 2.73013916 |
31 | Abnormal hair whorl (HP:0010721) | 2.69492299 |
32 | Truncal ataxia (HP:0002078) | 2.68551908 |
33 | Menstrual irregularities (HP:0000858) | 2.68438907 |
34 | Depression (HP:0000716) | 2.61491803 |
35 | Blue irides (HP:0000635) | 2.61271747 |
36 | Increased CSF protein (HP:0002922) | 2.59511092 |
37 | Abnormality of the corticospinal tract (HP:0002492) | 2.58628099 |
38 | Abnormal eating behavior (HP:0100738) | 2.56527519 |
39 | Abnormality of binocular vision (HP:0011514) | 2.55585684 |
40 | Diplopia (HP:0000651) | 2.55585684 |
41 | Agitation (HP:0000713) | 2.55053324 |
42 | Congenital primary aphakia (HP:0007707) | 2.50899161 |
43 | Nephrogenic diabetes insipidus (HP:0009806) | 2.49148911 |
44 | Amblyopia (HP:0000646) | 2.48250582 |
45 | Gaze-evoked nystagmus (HP:0000640) | 2.46410526 |
46 | Ketoacidosis (HP:0001993) | 2.38407622 |
47 | Papilledema (HP:0001085) | 2.31563502 |
48 | Epileptiform EEG discharges (HP:0011182) | 2.29364986 |
49 | Absent speech (HP:0001344) | 2.28686929 |
50 | Drooling (HP:0002307) | 2.26377332 |
51 | Excessive salivation (HP:0003781) | 2.26377332 |
52 | Ankle clonus (HP:0011448) | 2.22912699 |
53 | Limb dystonia (HP:0002451) | 2.21904762 |
54 | Polyphagia (HP:0002591) | 2.20362130 |
55 | Dysmetria (HP:0001310) | 2.19929618 |
56 | Failure to thrive in infancy (HP:0001531) | 2.19371566 |
57 | Mutism (HP:0002300) | 2.17799739 |
58 | Macroorchidism (HP:0000053) | 2.16006278 |
59 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.15683978 |
60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14941055 |
61 | Hyperthyroidism (HP:0000836) | 2.12936584 |
62 | Papillary thyroid carcinoma (HP:0002895) | 2.12531301 |
63 | Lower limb muscle weakness (HP:0007340) | 2.12262197 |
64 | Thyroid carcinoma (HP:0002890) | 2.10600357 |
65 | Dysdiadochokinesis (HP:0002075) | 2.09916141 |
66 | Abnormality of macular pigmentation (HP:0008002) | 2.09646245 |
67 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09155034 |
68 | Retinal dysplasia (HP:0007973) | 2.08113352 |
69 | Thyroid-stimulating hormone excess (HP:0002925) | 2.07871718 |
70 | Thyroiditis (HP:0100646) | 2.07675939 |
71 | Petechiae (HP:0000967) | 2.04486941 |
72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.04261786 |
73 | Specific learning disability (HP:0001328) | 2.02998970 |
74 | Psychosis (HP:0000709) | 2.00762303 |
75 | Hematochezia (HP:0002573) | 2.00178282 |
76 | Hypsarrhythmia (HP:0002521) | 2.00126998 |
77 | Genital tract atresia (HP:0001827) | 1.99976824 |
78 | Increased circulating renin level (HP:0000848) | 1.99335834 |
79 | Vaginal atresia (HP:0000148) | 1.98666709 |
80 | Vacuolated lymphocytes (HP:0001922) | 1.97359513 |
81 | Postural instability (HP:0002172) | 1.97349204 |
82 | Hypomagnesemia (HP:0002917) | 1.96081684 |
83 | Spinal canal stenosis (HP:0003416) | 1.96079142 |
84 | Dysostosis multiplex (HP:0000943) | 1.95303090 |
85 | Hypercortisolism (HP:0001578) | 1.93823169 |
86 | Progressive macrocephaly (HP:0004481) | 1.91674693 |
87 | Hypoventilation (HP:0002791) | 1.91216443 |
88 | Poor suck (HP:0002033) | 1.91141058 |
89 | Neurofibrillary tangles (HP:0002185) | 1.90610976 |
90 | Hemiparesis (HP:0001269) | 1.90231857 |
91 | Inability to walk (HP:0002540) | 1.89496723 |
92 | Acute necrotizing encephalopathy (HP:0006965) | 1.89225208 |
93 | Protruding tongue (HP:0010808) | 1.88679349 |
94 | Impaired vibratory sensation (HP:0002495) | 1.88096996 |
95 | Absent/shortened dynein arms (HP:0200106) | 1.87765587 |
96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87765587 |
97 | Poor eye contact (HP:0000817) | 1.87690879 |
98 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.85236245 |
99 | Widely spaced teeth (HP:0000687) | 1.81825016 |
100 | Bradykinesia (HP:0002067) | 1.80921580 |
101 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80840418 |
102 | Heterochromia iridis (HP:0001100) | 1.80818804 |
103 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80730114 |
104 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.79563880 |
105 | Decreased circulating renin level (HP:0003351) | 1.79528006 |
106 | T lymphocytopenia (HP:0005403) | 1.77992160 |
107 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.77514083 |
108 | Conjunctival hamartoma (HP:0100780) | 1.77296041 |
109 | Impaired smooth pursuit (HP:0007772) | 1.76683122 |
110 | Abnormality of salivation (HP:0100755) | 1.76236602 |
111 | Constricted visual fields (HP:0001133) | 1.75968982 |
112 | Generalized myoclonic seizures (HP:0002123) | 1.75895030 |
113 | Bundle branch block (HP:0011710) | 1.74738934 |
114 | Type II lissencephaly (HP:0007260) | 1.74729514 |
115 | Sensory axonal neuropathy (HP:0003390) | 1.74336274 |
116 | Neuronal loss in central nervous system (HP:0002529) | 1.73443639 |
117 | Fetal akinesia sequence (HP:0001989) | 1.72948238 |
118 | Neoplasm of the adrenal cortex (HP:0100641) | 1.72877665 |
119 | Hyperglycemia (HP:0003074) | 1.71790394 |
120 | Loss of speech (HP:0002371) | 1.70752065 |
121 | Gait ataxia (HP:0002066) | 1.70183570 |
122 | Torticollis (HP:0000473) | 1.69573068 |
123 | Gingival bleeding (HP:0000225) | 1.67881609 |
124 | Disinhibition (HP:0000734) | 1.67113881 |
125 | Thickened helices (HP:0000391) | 1.65452376 |
126 | Methylmalonic acidemia (HP:0002912) | 1.64918637 |
127 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.64429117 |
128 | Esotropia (HP:0000565) | 1.64247553 |
129 | Postural tremor (HP:0002174) | 1.64219263 |
130 | Choroideremia (HP:0001139) | 1.64006562 |
131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.63558971 |
132 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.63558971 |
133 | Ulnar claw (HP:0001178) | 1.63416436 |
134 | Abnormality of T cell number (HP:0011839) | 1.62720871 |
135 | Spastic gait (HP:0002064) | 1.62325376 |
136 | Stomatitis (HP:0010280) | 1.62098371 |
137 | Generalized hypopigmentation of hair (HP:0011358) | 1.61777947 |
138 | Exotropia (HP:0000577) | 1.61020047 |
139 | Scanning speech (HP:0002168) | 1.60663919 |
140 | Adrenal overactivity (HP:0002717) | 1.60610062 |
141 | Hyperphosphatemia (HP:0002905) | 1.60495040 |
142 | Poor coordination (HP:0002370) | 1.60147297 |
143 | Decreased central vision (HP:0007663) | 1.58983379 |
144 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.58870203 |
145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.58870203 |
146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.58870203 |
147 | Progressive neurologic deterioration (HP:0002344) | 1.57628002 |
148 | Hemiplegia (HP:0002301) | 1.56325039 |
149 | Split foot (HP:0001839) | 1.56151751 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.67438531 |
2 | CASK | 4.22023692 |
3 | MAP3K12 | 3.44160654 |
4 | RIPK4 | 2.99973606 |
5 | MAP2K7 | 2.74723103 |
6 | EPHA4 | 2.53327205 |
7 | EPHA3 | 2.49891489 |
8 | MAP3K4 | 2.45602563 |
9 | MAP3K9 | 2.32400515 |
10 | PRPF4B | 2.31769269 |
11 | MINK1 | 2.07539484 |
12 | NTRK1 | 1.94594316 |
13 | CAMKK2 | 1.93202402 |
14 | DAPK2 | 1.89809944 |
15 | ARAF | 1.84838249 |
16 | PLK2 | 1.78394619 |
17 | KSR2 | 1.76319543 |
18 | TRIM28 | 1.74025942 |
19 | TAOK3 | 1.73380724 |
20 | GRK5 | 1.67540640 |
21 | BMPR2 | 1.64790620 |
22 | MARK1 | 1.62465747 |
23 | PAK6 | 1.58119214 |
24 | MAP2K4 | 1.55664681 |
25 | FGFR2 | 1.54628823 |
26 | BRD4 | 1.49539831 |
27 | NTRK2 | 1.49503064 |
28 | MAP3K2 | 1.45769875 |
29 | MAPK13 | 1.41907708 |
30 | ERBB3 | 1.35211910 |
31 | FES | 1.33436564 |
32 | CDK5 | 1.31414810 |
33 | CAMKK1 | 1.31044850 |
34 | CDK19 | 1.21062900 |
35 | TNIK | 1.20475069 |
36 | UHMK1 | 1.20363423 |
37 | DAPK1 | 1.16332256 |
38 | PRKD3 | 1.15500975 |
39 | SIK3 | 1.14061024 |
40 | MAP3K6 | 1.11044619 |
41 | PRKCG | 1.09477813 |
42 | TEC | 1.07700072 |
43 | KIT | 1.04119057 |
44 | IRAK1 | 1.04087046 |
45 | FGFR3 | 1.03605306 |
46 | MAP3K13 | 1.03524587 |
47 | CAMK2A | 1.03159094 |
48 | AKT3 | 1.02272738 |
49 | PRKCH | 1.02125643 |
50 | SGK223 | 1.00902287 |
51 | SGK494 | 1.00902287 |
52 | TRPM7 | 1.00179115 |
53 | GRK7 | 0.99538161 |
54 | MAP3K5 | 0.98968124 |
55 | KSR1 | 0.97689349 |
56 | JAK2 | 0.94754915 |
57 | FGR | 0.91237609 |
58 | SGK2 | 0.91175763 |
59 | MAP3K1 | 0.90872272 |
60 | OXSR1 | 0.90534619 |
61 | TYK2 | 0.90408372 |
62 | PRKCE | 0.88005384 |
63 | ACVR1B | 0.81228243 |
64 | CAMK2B | 0.80816002 |
65 | ADRBK2 | 0.80675193 |
66 | PIK3CG | 0.79897606 |
67 | NME1 | 0.79793307 |
68 | INSRR | 0.77539927 |
69 | EPHB1 | 0.77228071 |
70 | MAPK7 | 0.76140038 |
71 | TNK2 | 0.75953682 |
72 | BCR | 0.73790255 |
73 | FRK | 0.72968665 |
74 | BLK | 0.72486348 |
75 | RAF1 | 0.70459819 |
76 | CDK14 | 0.70085214 |
77 | HCK | 0.68924890 |
78 | PTK2B | 0.68015715 |
79 | CSNK1G2 | 0.67050929 |
80 | TXK | 0.66601535 |
81 | HIPK2 | 0.66438330 |
82 | STK38 | 0.66309005 |
83 | RET | 0.66050135 |
84 | SGK1 | 0.64430815 |
85 | ITK | 0.64254292 |
86 | CAMK2D | 0.63050016 |
87 | ZAP70 | 0.62824510 |
88 | WNK1 | 0.62498046 |
89 | CDK18 | 0.61857948 |
90 | ADRBK1 | 0.61428900 |
91 | SIK2 | 0.61169237 |
92 | MAP4K2 | 0.60566613 |
93 | PINK1 | 0.59144497 |
94 | BCKDK | 0.59077541 |
95 | PAK3 | 0.59014499 |
96 | LIMK1 | 0.58405966 |
97 | LCK | 0.58090669 |
98 | BMPR1B | 0.57918343 |
99 | CSNK1G1 | 0.56919561 |
100 | CSNK1G3 | 0.56639988 |
101 | CDK15 | 0.55631869 |
102 | CAMK2G | 0.55091014 |
103 | BRAF | 0.54695932 |
104 | MAP3K14 | 0.54531079 |
105 | DYRK1B | 0.53903390 |
106 | SGK3 | 0.53706846 |
107 | NEK6 | 0.52143562 |
108 | NUAK1 | 0.51910119 |
109 | NLK | 0.50189790 |
110 | LYN | 0.50123815 |
111 | CSF1R | 0.49762960 |
112 | MAP4K1 | 0.49687139 |
113 | MUSK | 0.49285502 |
114 | DYRK1A | 0.48910055 |
115 | CDK11A | 0.47478056 |
116 | CSK | 0.47414363 |
117 | WNK4 | 0.46975155 |
118 | BTK | 0.46851169 |
119 | MST4 | 0.46341750 |
120 | PDK1 | 0.44117755 |
121 | SYK | 0.43649188 |
122 | CLK1 | 0.43585420 |
123 | FYN | 0.43163445 |
124 | YES1 | 0.42794061 |
125 | WNK3 | 0.41996148 |
126 | PDPK1 | 0.41896397 |
127 | STK11 | 0.41564586 |
128 | CAMK1 | 0.39154196 |
129 | IRAK2 | 0.37968963 |
130 | STK39 | 0.37824664 |
131 | PHKG2 | 0.37568969 |
132 | PHKG1 | 0.37568969 |
133 | PRKCQ | 0.37029452 |
134 | CDC42BPA | 0.36487254 |
135 | PRKG1 | 0.36274176 |
136 | JAK1 | 0.35475533 |
137 | PRKACA | 0.34333408 |
138 | PRKCA | 0.31462965 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.53608488 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.12016147 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.87008546 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.45219100 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42123994 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.40219036 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31408114 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.30175324 |
9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.25993539 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16172913 |
11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15238126 |
12 | Insulin secretion_Homo sapiens_hsa04911 | 2.10785152 |
13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.08985233 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96852724 |
15 | Taste transduction_Homo sapiens_hsa04742 | 1.84201052 |
16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80192744 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79663403 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69961499 |
19 | Salivary secretion_Homo sapiens_hsa04970 | 1.64664454 |
20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.61453093 |
21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61121503 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.60488230 |
23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52197248 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51895695 |
25 | Long-term depression_Homo sapiens_hsa04730 | 1.49729927 |
26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45390910 |
27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43627874 |
28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.42877678 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36395914 |
30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35279637 |
31 | Platelet activation_Homo sapiens_hsa04611 | 1.28667248 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27204679 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27163634 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.23611045 |
35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22347926 |
36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22027571 |
37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17405246 |
38 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16681002 |
39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12736595 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12443417 |
41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10972001 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09733777 |
43 | Phototransduction_Homo sapiens_hsa04744 | 1.07902223 |
44 | Phagosome_Homo sapiens_hsa04145 | 1.07408108 |
45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06843220 |
46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04854830 |
47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03041709 |
48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99706693 |
49 | Protein export_Homo sapiens_hsa03060 | 0.99497553 |
50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96728515 |
51 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94507396 |
52 | Allograft rejection_Homo sapiens_hsa05330 | 0.93651698 |
53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88982288 |
54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88695170 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87473515 |
56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86659822 |
57 | Gap junction_Homo sapiens_hsa04540 | 0.86131968 |
58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85220723 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84550407 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82317817 |
61 | Glioma_Homo sapiens_hsa05214 | 0.81635534 |
62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81186425 |
63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80131438 |
64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79139323 |
65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78677385 |
66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78211425 |
67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77091455 |
68 | Asthma_Homo sapiens_hsa05310 | 0.76584940 |
69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75585190 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.75420256 |
71 | Melanogenesis_Homo sapiens_hsa04916 | 0.72115628 |
72 | Legionellosis_Homo sapiens_hsa05134 | 0.71426550 |
73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71084094 |
74 | Axon guidance_Homo sapiens_hsa04360 | 0.69341954 |
75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68162589 |
76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67903782 |
77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66929761 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66180782 |
79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64940079 |
80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64913384 |
81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64793478 |
82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64717061 |
83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64488611 |
84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61655598 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61264056 |
86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60771614 |
87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59899711 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59511651 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59236963 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58563281 |
91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57550491 |
92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57042771 |
93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56223218 |
94 | Tuberculosis_Homo sapiens_hsa05152 | 0.55719650 |
95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55064626 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.53832908 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53612328 |
98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53136426 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52565649 |
100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51675016 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51507431 |
102 | Shigellosis_Homo sapiens_hsa05131 | 0.50812683 |
103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50262894 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48515445 |
105 | Pertussis_Homo sapiens_hsa05133 | 0.48460793 |
106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48192030 |
107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47102977 |
108 | Alcoholism_Homo sapiens_hsa05034 | 0.45896518 |
109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44757841 |
110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44569259 |
111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44541576 |
112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43401102 |
113 | Salmonella infection_Homo sapiens_hsa05132 | 0.42058276 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.41948445 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41367842 |
116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40317835 |
117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38881771 |
118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37035241 |
119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36422871 |
120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35556662 |
121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35516609 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34601135 |
123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34330186 |
124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33554652 |
125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33131520 |
126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33077879 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31871552 |
128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31089187 |
129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30020856 |